CYTOMEGALOVIRUS RETINITIS AND AIDS IN EDINBURGH

被引:6
作者
DHILLON, B
MACLEAN, H
EDDYSHAW, D
CHEONG, I
FLEGG, P
BRETTLE, R
机构
[1] Princess Alexandra Eye Pavilion, Edinburgh
[2] Regional Infectious Diseases Unit, City Hospital, Edinburgh
关键词
CYTOMEGALOVIRUS; RETINITIS; GANCICLOVIR; FOSCARNET; VISUAL OUTCOME;
D O I
10.1177/095646249300400607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The medical records, retinal drawings and fundus photographs of all patients with cytomegalovirus retinitis (CMVR) and AIDS in Edinburgh between 1986-1992 were reviewed to determine the efficacy of treatment in preserving vision. Ophthalmoscopic features of CMVR were observed in 32 eyes of 24 patients with AIDS, 19 males and 5 females. HIV transmission in this group was by homo/bisexual contact (16), injection drug use (7) and blood transfusion (1). Unilateral blurring was the commonest visual symptom although 9 (38%) patients had no visual symptoms. All patients presented with a corrected visual acuity of 6/12 or better in at least one eye. Following treatment with systemic ganciclovir or foscarnet 16 patients (66%) developed toxic side-effects of therapy and 13 (54%) experienced a recurrence of CMVR. Four (17%) patients developed a retinal detachment in one eye. The mean survival was 8.3 months after the diagnosis of CMVR. At final follow-up, between 2-26 months after the diagnosis of CMVR, 21 (87.5%) patients retained useful vision (6/18 or better) although 3 (12.5%) were effectively blind (less than 6/60). We conclude that with prompt diagnosis and treatment of CMVR vision can be preserved in the majority of cases.
引用
收藏
页码:339 / 341
页数:3
相关论文
共 10 条
[1]  
Jabs D.A., Enger C., Bartlett J.G., Cytomegalovirus retinitis and acquired immunodeficiency syndrome, Arch Ophthalmol, 107, pp. 75-80, (1989)
[2]  
Aids in Lothian-AIDS (Control) Act Report, (1990)
[3]  
Brettle R.P., Flegg P.J., MacCallum L., Injection drug use related HIV and AIDS, Recent advances in sexually transmitted diseases and AIDS, (1991)
[4]  
Peters B.S., Beck E.J., Anderson S., Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival, J Infection, 23, pp. 123-128, (1991)
[5]  
Palestine A.G., Rodrigues M.M., Macher A.M., Chan C.C., Lane H.C., Fauci A.S., Ophthalmic involvement in acquired immunodeficiency syndrome, Ophthalmology, 91, pp. 1092-1099, (1984)
[6]  
Khadem M., Kalish S.B., Goldsmith J.A., Fetkenhour C., O'Grady R.B., Phair J.P., Ophthalmologic findings in acquired immunodeficiency syndrome, Arch Ophthalmol, 102, pp. 201-204, (1984)
[7]  
Jabs D.A., Green W.R., Fox R., Polk F., Bartlett J.G., Ocular manifestations of acquired immune deficiency syndrome, Ophthalmology, 96, pp. 1092-1099, (1989)
[8]  
Holland G.N., Pepose J.S., Pettit T.H., Acquired immune deficiency syndrome
[9]  
ocular manifestations, Ophthalmology, 90, pp. 859-873, (1983)
[10]  
Henderly D.E., Freeman W.R., Causey D.M., Rao N.A., Cytomegalovirus retinitis and response to therapy with ganciclovir, Ophthalmology, 94, pp. 425-432, (1987)